+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Contraceptive Market Research Report by Drugs, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4829811
  • Report
  • January 2021
  • Region: Global
  • 184 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
The Global Contraceptive Market to Grow USD 101,758.61 Million by 2025, at a CAGR of 18.34%

FEATURED COMPANIES

  • Agile Therapeutics
  • Ani Pharmaceuticals Inc.
  • Church & Dwight Co., Inc.
  • Fuji Latex Co. Ltd
  • Johnson & Johnson
  • Merck & Co. Inc.
  • MORE
The Global Contraceptive Market to Grow USD 101,758.61 Million by 2025, at a CAGR of 18.34%



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Contraceptive Market is expected to grow from USD 43,827.88 Million in 2020 to USD 101,758.61 Million by the end of 2025.
2. The Global Contraceptive Market is expected to grow from EUR 38,429.12 Million in 2020 to EUR 89,223.88 Million by the end of 2025.
3. The Global Contraceptive Market is expected to grow from GBP 34,163.57 Million in 2020 to GBP 79,320.23 Million by the end of 2025.
4. The Global Contraceptive Market is expected to grow from JPY 4,677,545.79 Million in 2020 to JPY 10,860,223.06 Million by the end of 2025.
5. The Global Contraceptive Market is expected to grow from AUD 63,643.91 Million in 2020 to AUD 147,767.04 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drugs, the Contraceptive Market is examined across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches.
  • Based on Gender, the Contraceptive Market is examined across Female Contraceptive Devices and Male Contraceptive Devices.
  • Based on Distribution, the Contraceptive Market is examined across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
  • Based on Geography, the Contraceptive Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Contraceptive Market including Agile Therapeutics, Allergan Plc, Ani Pharmaceuticals Inc., Bayer Corporation, Church & Dwight Co., Inc., CooperSurgical, Inc., Fuji Latex Co. Ltd, Gilead Sciences Inc., Johnson & Johnson, Mayer Laboratories, Inc., Merck & Co. Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and Veru Inc..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. the ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Contraceptive Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Contraceptive Market?
4. What is the competitive strategic window for opportunities in the Global Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the Global Contraceptive Market?
6. What are the modes and strategic moves considered suitable for entering the Global Contraceptive Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agile Therapeutics
  • Ani Pharmaceuticals Inc.
  • Church & Dwight Co., Inc.
  • Fuji Latex Co. Ltd
  • Johnson & Johnson
  • Merck & Co. Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drugs Outlook
3.4. Gender Outlook
3.5. Distribution Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
5.1.1.3. Popularity of oral contraceptive pills in women of reproductive age
5.1.1.4. Easy of availability of various contraceptives, such as of contraceptive pills and condoms
5.1.2. Restraints
5.1.2.1. Side effects of oral contraceptive drugs
5.1.3. Opportunities
5.1.3.1. Government and non-government organizations supporting programs to encourage contraception in emerging economies
5.1.3.2. Growth opportunities for affordable contraceptives method such as Sino-Implants and novel contraceptive
5.1.4. Challenges
5.1.4.1. Lack of information and misconceptions about different contraceptives
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Contraceptive Market, By Drugs
6.1. Introduction
6.2. Contraceptive Injectable
6.3. Emergency Contraceptive Pills
6.4. Oral Contraceptives
6.5. Transdermal Patches

7. Global Contraceptive Market, By Gender
7.1. Introduction
7.2. Female Contraceptive Devices
7.3. Male Contraceptive Devices

8. Global Contraceptive Market, By Distribution
8.1. Introduction
8.2. Clinics
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform

9. Americas Contraceptive Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Contraceptive Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Contraceptive Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Agile Therapeutics
13.2. Allergan Plc
13.3. Ani Pharmaceuticals Inc.
13.4. Bayer Corporation
13.5. Church & Dwight Co., Inc.
13.6. CooperSurgical, Inc.
13.7. Fuji Latex Co. Ltd
13.8. Gilead Sciences Inc.
13.9. Johnson & Johnson
13.10. Mayer Laboratories, Inc.
13.11. Merck & Co. Inc.
13.12. Pfizer Inc
13.13. Reckitt Benckiser Group Plc
13.14. Teva Pharmaceuticals Industries Ltd.
13.15. Veru Inc.

14. Appendix
14.1. Discussion Guide

List of Figures
Figure 1. Global Contraceptive Market: Research Process
Figure 2. Global Contraceptive Market: Research Execution
Figure 3. Global Contraceptive Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Contraceptive Market Size, by Drugs, 2020 (USD Million)
Figure 5. Global Contraceptive Market Size, by Gender, 2020 (USD Million)
Figure 6. Global Contraceptive Market Size, by Distribution, 2020 (USD Million)
Figure 7. Global Contraceptive Market Size, by Geography, 2020 (USD Million)
Figure 8. Global Contraceptive Market Size, 2018-2025 (USD Million)
Figure 9. Global Contraceptive Market Size, by Geography, 2020 Vs 2025 (%)
Figure 10. Global Contraceptive Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 11. Competitive Strategic Window for Global Contraceptive Market Size, by Geography, 2025
Figure 12. Global Contraceptive Market: Market Dynamics
Figure 13. Global Contraceptive Market: Porters Five Forces Analysis
Figure 14. Global Contraceptive Market Size, by Drugs, 2020 Vs 2025 (%)
Figure 15. Global Contraceptive Market Size, by Drugs, 2020 Vs 2025 (USD Million)
Figure 16. Competitive Strategic Window for Global Contraceptive Market Size, by Drugs, 2025
Figure 17. Global Contraceptive Market Size, by Contraceptive Injectable, 2020 Vs 2025 (USD Million)
Figure 18. Global Contraceptive Market Size, by Emergency Contraceptive Pills, 2020 Vs 2025 (USD Million)
Figure 19. Global Contraceptive Market Size, by Oral Contraceptives, 2020 Vs 2025 (USD Million)
Figure 20. Global Contraceptive Market Size, by Transdermal Patches, 2020 Vs 2025 (USD Million)
Figure 21. Global Contraceptive Market Size, by Gender, 2020 Vs 2025 (%)
Figure 22. Global Contraceptive Market Size, by Gender, 2020 Vs 2025 (USD Million)
Figure 23. Competitive Strategic Window for Global Contraceptive Market Size, by Gender, 2025
Figure 24. Global Contraceptive Market Size, by Female Contraceptive Devices, 2020 Vs 2025 (USD Million)
Figure 25. Global Contraceptive Market Size, by Male Contraceptive Devices, 2020 Vs 2025 (USD Million)
Figure 26. Global Contraceptive Market Size, by Distribution, 2020 Vs 2025 (%)
Figure 27. Global Contraceptive Market Size, by Distribution, 2020 Vs 2025 (USD Million)
Figure 28. Competitive Strategic Window for Global Contraceptive Market Size, by Distribution, 2025
Figure 29. Global Contraceptive Market Size, by Clinics, 2020 Vs 2025 (USD Million)
Figure 30. Global Contraceptive Market Size, by Hospital Pharmacy, 2020 Vs 2025 (USD Million)
Figure 31. Global Contraceptive Market Size, by Independent Pharmacy, 2020 Vs 2025 (USD Million)
Figure 32. Global Contraceptive Market Size, by Online Platform, 2020 Vs 2025 (USD Million)
Figure 33. Americas Contraceptive Market Size, by Geography, 2020 Vs 2025 (%)
Figure 34. Americas Contraceptive Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 35. Competitive Strategic Window for Americas Contraceptive Market Size, by Geography, 2025
Figure 36. Argentina Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 37. Brazil Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 38. Canada Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. Mexico Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. United States Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. Asia-Pacific Contraceptive Market Size, by Geography, 2020 Vs 2025 (%)
Figure 42. Asia-Pacific Contraceptive Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 43. Competitive Strategic Window for Asia-Pacific Contraceptive Market Size, by Geography, 2025
Figure 44. Australia Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 45. China Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. India Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. Indonesia Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Japan Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Malaysia Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Philippines Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. South Korea Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. Thailand Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Europe, Middle East & Africa Contraceptive Market Size, by Geography, 2020 Vs 2025 (%)
Figure 54. Europe, Middle East & Africa Contraceptive Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 55. Competitive Strategic Window for Europe, Middle East & Africa Contraceptive Market Size, by Geography, 2025
Figure 56. France Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. Germany Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. Italy Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Netherlands Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Qatar Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Russia Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Saudi Arabia Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. South Africa Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. Spain Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. United Arab Emirates Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. United Kingdom Contraceptive Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. Global Contraceptive Market: FPNV Positioning Matrix
Figure 68. Global Contraceptive Market: Market Share Analysis
Figure 69. Global Contraceptive Market: Competitor SWOT Analysis
Figure 70. Competitive Scenario Analysis in Global Contraceptive Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Contraceptive Market Size, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 3. Global Contraceptive Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 4. Global Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 5. Global Contraceptive Market Size, by Contraceptive Injectable, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 6. Global Contraceptive Market Size, by Emergency Contraceptive Pills, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 7. Global Contraceptive Market Size, by Oral Contraceptives, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 8. Global Contraceptive Market Size, by Transdermal Patches, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 9. Global Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 10. Global Contraceptive Market Size, by Female Contraceptive Devices, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 11. Global Contraceptive Market Size, by Male Contraceptive Devices, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 12. Global Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 13. Global Contraceptive Market Size, by Clinics, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 14. Global Contraceptive Market Size, by Hospital Pharmacy, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 15. Global Contraceptive Market Size, by Independent Pharmacy, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 16. Global Contraceptive Market Size, by Online Platform, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 17. Americas Contraceptive Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 18. Americas Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 19. Americas Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 20. Americas Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 21. Argentina Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 22. Argentina Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 23. Argentina Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 24. Brazil Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 25. Brazil Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 26. Brazil Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 27. Canada Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 28. Canada Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 29. Canada Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 30. Mexico Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 31. Mexico Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 32. Mexico Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 33. United States Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 34. United States Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 35. United States Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 36. Asia-Pacific Contraceptive Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 37. Asia-Pacific Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 38. Asia-Pacific Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 39. Asia-Pacific Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 40. Australia Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 41. Australia Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 42. Australia Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 43. China Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 44. China Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 45. China Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 46. India Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 47. India Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 48. India Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 49. Indonesia Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 50. Indonesia Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 51. Indonesia Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 52. Japan Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 53. Japan Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 54. Japan Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 55. Malaysia Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 56. Malaysia Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 57. Malaysia Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 58. Philippines Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 59. Philippines Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 60. Philippines Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 61. South Korea Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 62. South Korea Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 63. South Korea Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 64. Thailand Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 65. Thailand Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 66. Thailand Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 67. Europe, Middle East & Africa Contraceptive Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 68. Europe, Middle East & Africa Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 69. Europe, Middle East & Africa Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 70. Europe, Middle East & Africa Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 71. France Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 72. France Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 73. France Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 74. Germany Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 75. Germany Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 76. Germany Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 77. Italy Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 78. Italy Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 79. Italy Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 80. Netherlands Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 81. Netherlands Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 82. Netherlands Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 83. Qatar Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 84. Qatar Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 85. Qatar Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 86. Russia Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 87. Russia Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 88. Russia Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 89. Saudi Arabia Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 90. Saudi Arabia Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 91. Saudi Arabia Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 92. South Africa Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 93. South Africa Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 94. South Africa Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 95. Spain Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 96. Spain Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 97. Spain Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 98. United Arab Emirates Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 99. United Arab Emirates Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 100. United Arab Emirates Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 101. United Kingdom Contraceptive Market Size, by Drugs, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 102. United Kingdom Contraceptive Market Size, by Gender, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 103. United Kingdom Contraceptive Market Size, by Distribution, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 104. Global Contraceptive Market: Scores
Table 105. Global Contraceptive Market: Business Strategy
Table 106. Global Contraceptive Market: Product Satisfaction
Table 107. Global Contraceptive Market: Ranking
Table 108. Global Contraceptive Market: Merger & Acquisition
Table 109. Global Contraceptive Market: Agreement, Collaboration, & Partnership
Table 110. Global Contraceptive Market: New Product Launch & Enhancement
Table 111. Global Contraceptive Market: Investment & Funding
Table 112. Global Contraceptive Market: Award, Recognition, & Expansion
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Agile Therapeutics
  • Allergan Plc
  • Ani Pharmaceuticals Inc.
  • Bayer Corporation
  • Church & Dwight Co., Inc.
  • CooperSurgical, Inc.
  • Fuji Latex Co. Ltd
  • Gilead Sciences Inc.
  • Johnson & Johnson
  • Mayer Laboratories, Inc.
  • Merck & Co. Inc.
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Teva Pharmaceuticals Industries Ltd.
  • Veru Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll